Skip to main content
1004-2013, 1005-2016, 1004-2009, 1005-2017, 1006-2023, 1004-2010, 1004-2011, 1003-2006, 1005-2014, 1006-2018, 1001-2001, 1006-2020, 1006-2019, 1001-2002, 1005-2015, 1006-2021, 1006-2022, 1002-2005, 1002-2004, 1006-2024, 1003-2007, 1006-2025, 1004-2012, 1006-2027, 1001-2003, 1006-2026, 1003-2008, 1006-2028
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_503728,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_503728_Top-Ten-2019-CVD-Primary-Prevention-Guideline.jsp,docTitle=Top Ten: 2019 CVD Primary Prevention Guideline,xWebsites=professional,dDocAuthor=stacy.ragsdale,xNextReviewDate=09/21/2016 5:30 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=The top things to you should know about 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=guidelines, antihypertensive agents, aspirin, atherosclerosis, atherosclerotic cardiovascular disease, atrial fibrillation, behavior modification, behavior therapy, blood cholesterol, blood pressure, body mass, index, cardiovascular team-based care, cardiovascular, cardiovascular disease, cholesterol, chronic kidney disease, coronary artery calcium score, coronary disease, coronary heart disease, cost, diet, dietary patterns, dietary fats, dietary sodium, dyslipidemia, e-cigarettes, exercise, healthcare disparities, health services accessibility, heart failure, hypertension, LDL-cholesterol, diabetes mellitus, lifestyle, lipids, measurement, myocardial infarction, nicotine, nonpharmacological treatment, nutrition, physical activity, prejudice, primary prevention, psychosocial deprivation, public health, quality indicators, quality measurement, risk assessment, risk-enhancing factors, risk factors, risk reduction, risk reduction discussion, risk treatment discussion, secondhand smoke, sleep, smoking, smoking cessation, social determinants of health, socioeconomic factors, statin therapy, systems of care, tobacco, tobacco smoke pollution, treatment adherence, treatment outcomes, type 2 diabetes mellitus, waist circumference, weight loss,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SMD,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=03/16/2019 8:10 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=03/17/2019 7:00 PM,xWebsiteSection=professional:1463,dDocName=UCM_503728,dpAction=null,dRevLabel=1,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_503728.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=1,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=503728,dIsPrimary=1,dFileSize=22818,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1882943,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=03/17/2019 7:03 PM,xTrashDeleteLoc=null,dCreateDate=03/16/2019 8:10 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=03/17/2019 7:00 PM,xRobotParameter=,xCommunities=1004-2013, 1005-2016, 1004-2009, 1005-2017, 1006-2023, 1004-2010, 1004-2011, 1003-2006, 1005-2014, 1006-2018, 1001-2001, 1006-2020, 1006-2019, 1001-2002, 1005-2015, 1006-2021, 1006-2022, 1002-2005, 1002-2004, 1006-2024, 1003-2007, 1006-2025, 1004-2012, 1006-2027, 1001-2003, 1006-2026, 1003-2008, 1006-2028,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

Top Things to Know:
2019 CVD Primary Prevention Guideline

  1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.
  2. A team-based care approach is an effective strategy for the prevention of cardiovascular disease. Clinicians should evaluate the social determinants of health that affect individuals to inform treatment decisions.
  3. Adults who are 40 to 75 years of age and are being evaluated for cardiovascular disease prevention should undergo 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation and have a clinician–patient risk discussion before starting on pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. In addition, assessing for other risk-enhancing factors can help guide decisions about preventive interventions in select individuals, as can coronary artery calcium scanning.
  4. All adults should consume a healthy diet that emphasizes the intake of vegetables, fruits, legumes, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the intake of trans fats, processed meats, refined carbohydrates, and sweetened beverages. For adults with overweight/obesity , comprehensive lifestyle interventions, including counseling and caloric restriction, are recommended for achieving and maintaining weight loss.
  5. Adults should engage in at least 150 minutes per week of accumulated moderate-intensity physical activity or 75 minutes per week of vigorous-intensity physical activity.                                        
  6. For adults with type 2 diabetes mellitus, lifestyle changes, such as improving dietary habits and achieving exercise recommendations, are crucial. If medication is indicated, metformin is first-line therapy, followed by consideration of a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist.
  7. All adults should be assessed at every healthcare visit for tobacco use, and those who use tobacco should be assisted and strongly advised to quit. 
  8. Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit.
  9. Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low-density lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion.
  10. Nonpharmacological interventions are recommended for all adults with elevated blood pressure or hypertension. For those requiring pharmacological therapy, the target blood pressure should generally be <130/80 mm Hg.

View the full Science News coverage for 2019 CVD Primary Prevention Guideline

Citation

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published online ahead of print March 17, 2019]. Circulation. 2019: ????????. DOI: 10.1161/CIR.0000000000000678.